icon-folder.gif   Conference Reports for NATAP  
 
  64rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Washington, DC Nov 1-5 2013
Back grey_arrow_rt.gif
 
 
 
Safety Profile of Peginterferon Lambda for Treatment of Chronic Hepatitis B (CHB) or Chronic Hepatitis C (CHC): Cross-Study Analysis of Patients Treated in Three Phase 2 Studies
 
 
  Reported by Jules Levin
AASLD 2013 Nov 1-5 Wash DC
 
Muir AJ,1 Jurkowski C,2 Cooney E,2 Hillson J,3 Lataillade M,2 Mas Casullo V,2 Gray T,3 Xu D,2 Yogendran L,2 Srinivasan S2
1Duke Clinical Research Institute, Duke University, Durham, NC; 2Bristol-Myers Squibb, Wallingford, CT; 3Bristol-Myers Squibb/Zymogenetics, Seattle, WA

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif

AASLD13.gif

AASLD14.gif